金妇康品牌怎么样 申请店铺

更新时间:2024-03-05
金妇康是哪个国家的品牌?「金妇康」是 中华茂祥集团有限公司 旗下著名品牌。该品牌发源于吉林省通化市,由创始人王瀚基在1996-02-08期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
金妇康怎么样

创建于1984年,乌鸡白凤丸行业知名品牌,以医药为主,兼营房产/葡萄酒等生产的多元化集团企业


中华茂祥集团有限公司创业于1984年,经过二十年的不懈努力,公司已发展为医药为主,同时兼营房产、葡萄酒等生产,总资产12.5亿元的多元化的集团企业。占地面积65万平方米,总建筑面积5.5万平方米,员工近5000人,市场网络遍布全国。集团下设通化茂祥制药有限公司、通化茂祥药业股份有限公司、茂祥集团(长春)制药有限公司、茂祥集团(吉林)制药有限公司、吉林省祥和房地产开发有限公司、通化茂祥葡萄酒股份有限公司、通化市新华彩印厂等多家子公司。

多年来,中华茂祥集团有限公司本着开拓进取、求实创新的宗旨,为对社会、对人民高度负责的态度,自主经营、自我发展,注重产品开发,信守“营造健康、维护健康和为生命创造奇迹”的理念,坚持科技创新,科技投入达到年销售收入的15%以上,加速成果转化和新药品的产业化,立足医药,不断增强医药产业核心竞争力,使茂祥集团的经济发展呈现出良性循环的可喜势头。集团现有按国家GMP标准设计的注射用抗生素粉针剂和固体制剂、液体制剂等多条制药生产线,可生产化学合成原料药和胶囊剂(含缓释剂、控释制剂)、片剂(含缓释剂、控释剂)、颗粒剂、粉针剂、水针剂、软胶囊、滴丸、口服液、糖浆剂、软膏、栓剂、蜜丸13种剂型289个品种。公司生产系列中西药产品泰克、金妇康、安神胶囊、先泰、普舒等以良好的疗效赢得广大患者的认可,成为国内出色品牌。


Founded in 1984, Zhonghua Maoxiang Group Co., Ltd., a well-known brand in Wuji Baifeng pill industry, was founded in 1984. After 20 years of unremitting efforts, the company has developed into a diversified group enterprise with a total assets of 1.25 billion yuan, mainly engaged in the production of real estate and wine. Covering an area of 650000 square meters, with a total construction area of 55000 square meters and nearly 5000 employees, the market network covers the whole country. The group consists of Tonghua Maoxiang Pharmaceutical Co., Ltd., Tonghua Maoxiang Pharmaceutical Co., Ltd., Maoxiang group (Changchun) Pharmaceutical Co., Ltd., Maoxiang group (Jilin) Pharmaceutical Co., Ltd., Jilin Xianghe Real Estate Development Co., Ltd., Tonghua Maoxiang Wine Co., Ltd., Tonghua Xinhua color printing factory and other subsidiaries. Over the years, China Maoxiang Group Co., Ltd. adheres to the tenet of pioneering, realistic and innovative, pays attention to product development, adheres to the philosophy of "creating health, maintaining health and creating miracles for life", adheres to scientific and technological innovation, achieves more than 15% of annual sales revenue in scientific and technological investment, and accelerates the transformation of achievements And the industrialization of new drugs, based on medicine, constantly enhance the core competitiveness of the pharmaceutical industry, so that the economic development of Maoxiang group presents a positive cycle of gratifying momentum. At present, the group has many pharmaceutical production lines designed according to the national GMP standards, such as antibiotic powder for injection, solid preparation and liquid preparation, which can produce chemical synthetic APIs and capsules (including sustained-release and controlled-release preparations), tablets (including sustained-release and controlled-release agents), granules, powder injection, water injection, soft capsule, drop pill, oral liquid, syrup, ointment, suppository and honeypill 13 289 kinds of dosage forms. The company produces a series of Chinese and Western medicine products, such as Taike, Jinfukang, Anshen capsule, Xiantai, proshu, etc., which win the recognition of the majority of patients with good curative effect and become an excellent brand in China.

本文链接: https://brand.waitui.com/7da436a8d.html 联系电话:04353197011

7×24h 快讯

国产商用飞机C919及ARJ21首次飞抵柬埔寨

当地时间3月5日上午,中国生产的大型客机C919和ARJ21支线飞机飞抵柬埔寨金边国际机场。这是该两款机型飞机首次飞抵柬埔寨。根据安排,C919飞机将在当地进行静态展示,ARJ21飞机将在金边至暹粒的往返路线进行演示飞行。(央视新闻)

2小时前

光刻机概念股午后异动,双乐股份涨超13%

36氪获悉,截至发稿,光刻机概念股午后异动,双乐股份涨超13%,张江高科、广信材料、波长光电、容大感光、冠石科技等涨幅居前。

2小时前

多模态AI概念震荡走高,万兴科技涨超10%

36氪获悉,截至发稿,多模态AI概念震荡走高,万兴科技、凡拓数创涨超10%,丝路视觉、焦点科技、昆仑万维等纷纷跟涨。

2小时前

机构:2023年第四季DRAM产业营收季增近三成

36氪获悉,据集邦咨询研究显示,受惠于备货动能回温,以及三大原厂控产效益显现,主流产品的合约价格走扬,带动2023年第四季全球DRAM产业营收达174.6亿美元,季增29.6%。目前观察2024年第一季DRAM市场趋势,原厂目标仍为改善获利,涨价意图强烈,促使DRAM合约价季涨幅近两成,然出货位元则面临传统淡季而略微衰退。

2小时前

万科债券午后跌幅扩大

36氪获悉,万科债券午后跌幅扩大,截至发稿,“20万科04”跌超10%,“20万科06”跌超9%,“21万科02”跌超8%,“20万科02”跌超8%,“22万科01”跌超7%。

2小时前

本页详细列出关于金妇康的品牌信息,含品牌所属公司介绍,金妇康所处行业的品牌地位及优势。
咨询